(Total Views: 60)
Posted On: 04/05/2021 10:15:49 AM
Post# of 36539
$BPTH News Article - Bio-Path Holdings Announces Successful Completion of Safety Cohort of Triple Combination of Prexigebersen, Decitabine and Venetoclax in Stage 2 of Phase 2 Clinical Trial in Acute Myeloid Leukemia https://marketwirenews.com/news-releases/bio-...87875.html
(0)
(0)
My Twitter: WhyteStocks
